Systemic lupus erythematosus and drugs of ingredients of abiraterone acetate - a phase IV clinical study of FDA data


Summary:

Systemic lupus erythematosus is reported only by a few people who take drugs with ingredients of abiraterone acetate. This phase IV clinical study analyzes 36,550 people who have side effects while taking drugs with ingredients of abiraterone acetate from the the FDA. Among them, 2 have Systemic lupus erythematosus. Find out below who they are, when they have Systemic lupus erythematosus and more.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Abiraterone acetate, Yonsa, Zytiga.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.


On Oct, 01, 2022

36,550 people reported to have side effects when taking drugs with ingredients of abiraterone acetate.
Among them, 2 people (0.01%) have Systemic lupus erythematosus


What is Systemic lupus erythematosus?

Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue) is found to be associated with 2,094 drugs and 1,449 conditions by eHealthMe.

Number of reports submitted per year:

Could drugs with ingredients of abiraterone acetate cause Systemic lupus erythematosus?

Time on drugs with ingredients of abiraterone acetate when people have Systemic lupus erythematosus *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 100 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Systemic lupus erythematosus when taking drugs with ingredients of abiraterone acetate *:

  • female: 50 %
  • male: 50 %

Age of people who have Systemic lupus erythematosus when taking drugs with ingredients of abiraterone acetate *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Conditions people have *:

  1. Osteoporosis (bones weak and more likely to break): 1 person, 50.00%
  2. High Blood Pressure: 1 person, 50.00%
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 50.00%

Other drugs people take *:

  1. Reclast: 1 person, 50.00%
  2. Prednisone: 1 person, 50.00%
  3. Lisinopril: 1 person, 50.00%
  4. Aspirin: 1 person, 50.00%

Other side effects people have besides Systemic lupus erythematosus *:

  1. Sneezing: 1 person, 50.00%
  2. Procedural Pain: 1 person, 50.00%
  3. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 1 person, 50.00%
  4. Ocular Neoplasm (eye tumour): 1 person, 50.00%
  5. Neck Mass (mass in neck): 1 person, 50.00%
  6. Muscle Spasms (muscle contraction): 1 person, 50.00%
  7. Malaise (a feeling of general discomfort or uneasiness): 1 person, 50.00%
  8. Influenza Like Illness: 1 person, 50.00%
  9. Hepatic Enzyme Increased: 1 person, 50.00%
  10. Headache (pain in head): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.


How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Drugs with ingredients of abiraterone acetate, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on abiraterone acetate. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: